跳至主要内容
临床试验/NCT03937180
NCT03937180已完成不适用

The Effectiveness of a Blended Care Program for the Discontinuation of Benzodiazepines Use for Sleeping Problems in Primary Care: a Clustered Randomized Trial.

Kristien Coteur175 个研究点 分布在 1 个国家目标入组 924 人开始时间: 2019年6月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
924
试验地点
175
主要终点
Proportion of patients that discontinued (z-)BZD use at 12 months assessed by toxicological screening

研究概览

简要总结

This study aims to compare two strategies performed by GPs to help patients taking benzodiazepines on a daily basis for at least six months to discontinue their use. The first strategy consists of the usual or standard support provided by the GP, which often starts with a discontinuation advice or letter, the second is blended support where face-to-face consultations with the GP are alternated with web-based self-learning by the patient.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 18 and older capable of giving informed consent,
  • Having his/her Global Medical File managed by one of the participating general practitioners
  • Receiving prescriptions of (z-)BZDs from participating GP for use on a daily basis
  • Reporting daily intake (≥ 80% of days) of (z-)BZDs in the last 6 months for a primary indication of sleeping problems

排除标准

  • Presence of any severe psychiatric and neurologic condition that in the judgment of the treating GP implies a contraindication for (z-)BZD withdrawal
  • Presence of terminal illness
  • Any cases where stopping of (z-)BZDs might be harmful
  • Unwillingness or inability to provide informed consent
  • Not having e-literacy (being familiar with email and internet use)
  • Patients with a substance use disorder (other than (z-)BZD) will also be excluded from the study because in these cases there is often a sub-therapeutic (z-)BZD dependence and/or comorbid psychological/psychiatric comorbid conditions requiring specialist care.

结局指标

主要结局

Proportion of patients that discontinued (z-)BZD use at 12 months assessed by toxicological screening

时间窗: 12 months

Long-term effect of a blended care approach versus usual care on the discontinuation of (z-)BZD

次要结局

  • Proportion of patients that discontinued (z-)BZD use at 6 months assessed by toxicological screening(6 months)
  • EQ-5D-3L assessed at week 6, 12, 26 and 52(12 months)
  • Proportion of patients with self-reported discontinuation of (z-)BZD use assessed at week 6, 12, 26 and 52(12 months)
  • The number of defined daily doses (DDD) of (z-)BZD prescribed in the preceding interval assessed at week 6, 12, 26 and 52(12 months)

研究者

申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Kristien Coteur

Project manager - p.p. Chief investigator prof. dr. Catharina Matheï

KU Leuven

研究点 (175)

Loading locations...

相似试验